It appears so. Up 22% on swiss exchange. We have
Post# of 148165
There is room for more than one EUA between the two companies. It will be interesting to see how the FDA responds. I have my thoughts as to why they will look more favorably toward RLFTF, but I will keep those to myself for now.
Our drug is amazing and has no side effects. Manage your investments in CYDY accordingly.
GLTA longs and to life saving covid drugs. Lord knows we need as many as we can get not named remdesivir